chevron_leftBack
As of 16 June 2026, Guobang Pharma Ltd. has a market cap of $1.97B USD, ranking #7118 globally and #1745 in China.
It ranks #570 in the Healthcare sector, and #222 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$1.97BUSD
13.37B CNY
Enterprise Value
$1.71BUSD
11.6B CNY
Revenue (TTM)
$899.7MUSD
6.09B CNY
EBITDA (TTM)
$203.42MUSD
1.38B CNY
Net Income (TTM)
$113.19MUSD
766.47M CNY
EBITDA Margin
23%
Profit Margin
13%
PE Ratio
17.2
PS Ratio
2.2
PB Ratio
1.5
EV/EBITDA
8.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Shixue Liao
open_in_new
Employees
4,251
Founded
1996
Website
gbgcn.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.2% | 0.5% | -10% | -12% | 6.2% | 26% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
605507
国邦医药集团股份有限公司 Class A
ISIN: CNE100004NS2
Shares Out.:
Shares Outstanding:
782.353M1
Shares Float:
256.85M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
23.92 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Guobang Pharma Ltd.
Guobang Pharma Ltd. engages in the research, development, production, and sale of products in the pharmaceutical and veterinary industries. The company offers pharmaceutical products, including quinolones, macrolides, cephalosporins, characteristic APIs, preparations and accessories, and key pharmaceutical intermediates; and mobile protection APIs, kinetophoretic preparations, and feed additives. It sells its products approximately in 117 countries and regions worldwide. The company was founded in 1996 and is based in Xinchang, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.89B
3K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.67B
2K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
1K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
852%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.52B
737%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
711%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
38K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
28K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
18K%
|
97.4
|
|
SIX: RO
|
$322.73B
16K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.3B
15K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$275.68B
14K%
218.9B CHF
|
20.5
|
chevron_leftBack